Mobile Heartbeat Expands Banyan Platform with Private 5G Support for Healthcare Communications Mobile Heartbeat, a provider of clinical communication and collaboration solutions, has announced that its Banyan platform now supports…
IMDS Launches NHanceIT Microcatheter in the U.S. for Complex Coronary Interventions Interventional Medical Device Solutions (IMDS), a specialty catheter company developing purpose-built technologies for complex percutaneous coronary intervention (PCI), chronic…
BioLab Holdings Expands Placental Membrane Portfolio With New Membrane Wrap Amniotic Hydro BioLab Holdings, Inc., a Phoenix-based medical technology company focused on tissue restoration, has expanded its portfolio of placental…
PureTech Health Notes Positive Phase 1 Driving Trial Results for GlyphAllo in Major Depressive Disorder PureTech Health plc (LSE: PRTC), a biotherapeutics company operating through a hub-and-spoke model to translate…
InduPro Publishes Nature Study Defining New Proximity-Based Targets for Cancer Therapeutics InduPro, Inc., a biotechnology company developing novel therapeutics for cancer and autoimmune diseases through protein proximity biology, has announced…
TRIANA Biomedicines Publishes Nature Study Supporting TRI-611 Molecular Glue Therapy for ALK-Positive NSCLC TRIANA Biomedicines, Inc. (TRIANA), a clinical-stage biopharmaceutical company focused on developing molecular glue therapies against difficult-to-drug disease…
Flatiron Health and NCCN Renew Collaboration to Expand Real-World Evidence Research in Oncology Flatiron Health, a leading healthtech company focused on improving cancer care and advancing oncology research through real-world…
Gossamer Bio Announces 1-for-80 Reverse Stock Split to Regain Nasdaq Compliance Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on developing and commercializing seralutinib for pulmonary vascular diseases,…
PhenoNet Completes Enrollment in Phase IIb Trial of PHENOGENE-1A for ALS PhenoNet, Inc., a clinical-stage biotechnology company developing investigational therapies for neurodegenerative diseases, has announced the completion of recruitment and…
TwoStep Therapeutics Secures $62.5 Million Series A and FDA Clearance for TS-104 Phase 1 Trial TwoStep Therapeutics, a biotechnology company developing multi-specific targeted therapies for solid tumors, has announced two…
Lotus Neuro Launches to Advance Focused Ultrasound Drug Delivery for Neurological Diseases Lotus Neuro, a clinical-stage biotechnology company focused on combining focused ultrasound with therapeutic medicines to address focal neurological…
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-663 for Multiple Cancers Crossbow Therapeutics, Inc., a biotechnology company developing targeted antibody therapies designed to address a broad range…